Not applicableUnknownNCT05383014What this trial is testingFLT3-ITD Gene Mutation and CD135 Expression in Acute Myeloid Leukemia.Who this might be right forAcute Myeloid Leukemia Assiut University 82
Not applicableStudy completedNCT01138306What this trial is testingBiomarkers in Samples From Young Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Children's Oncology Group 149
Early research (Phase 1)Study completedNCT01149915What this trial is testingStudy of Hypoxia-Activated Prodrug TH-302 to Treat Advanced LeukemiasWho this might be right forAcute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+3 more Threshold Pharmaceuticals 40
Not applicableEnded earlyNCT00253552What this trial is testingG-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more OHSU Knight Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT00863148What this trial is testingAllogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)Who this might be right forMDSAMLALL+1 more Nantes University Hospital 30
Early research (Phase 1)Ended earlyNCT05712278What this trial is testingInvestigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukaemia Sanofi 7
Not applicableStudy completedNCT00499785What this trial is testingPhysical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forCognitive/Functional EffectsDepressionLeukemia Wake Forest University Health Sciences 11
Testing effectiveness (Phase 2)Study completedNCT00003335What this trial is testingUmbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Case Comprehensive Cancer Center 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06652685What this trial is testingMolecular Subtype Combined with Early Minimal Residual Disease to Optimize the Treatment of Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia (AML) Ruijin Hospital 218
Not applicableWithdrawnNCT05943314What this trial is testingClinical Study on Safety and Efficacy of Anti-CLL1 /+CD33 CAR T Cells in the Treatment of Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Guangzhou Bio-gene Technology Co., Ltd
Early research (Phase 1)Looking for participantsNCT06191978What this trial is testingA Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia M.D. Anderson Cancer Center 40
Not applicableStudy completedNCT04908852What this trial is testingFeasibility Pilot Exploring Variability in Biomarkers and PROs in AMLWho this might be right forAcute Myeloid Leukemia (AML) Dana-Farber Cancer Institute 10
Not applicableStudy completedNCT02598752What this trial is testingFeasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell TransplantationWho this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromeHematological Malignancy+3 more Memorial Sloan Kettering Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT01253447What this trial is testingAKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)WithdrawnNCT04044209What this trial is testingThe IDH1 Inhibitor AG-120 in Combination With the Checkpoint Blockade Inhibitor, Nivolumab, for Patients With IDH1 Mutated Relapsed/Refractory AML and High Risk MDSWho this might be right forMyelodysplastic SyndromesAcute Myeloid Leukemia Yale University
Testing effectiveness (Phase 2)Looking for participantsNCT06191263What this trial is testingSafety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AMLWho this might be right forAcute Myeloid Leukemia Ryvu Therapeutics SA 98
Early research (Phase 1)Looking for participantsNCT05945849What this trial is testingCD33KO-HSPC Infusion Followed by CART-33 Infusion(s) for Refractory/Relapsed AMLWho this might be right forLeukemia, Myeloid, Acute University of Pennsylvania 16
Testing effectiveness (Phase 2)Study completedNCT04992949What this trial is testingEvaluation of CPX-351 Monotherapy in Acute Myeloid Leukemia Secondary to Myeloproliferative NeoplasmWho this might be right forAcute Myeloid LeukemiaMyeloproliferative Syndrome French Innovative Leukemia Organisation 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT05656248What this trial is testingStudy of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid NeoplasmsWho this might be right forMyeloid Neoplasm St. Jude Children's Research Hospital 25
Large-scale testing (Phase 3)Not Yet RecruitingNCT07735117What this trial is testingMitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax vs. Azacitidine Plus Venetoclax for MDS-IB2 and Secondary/Elderly AMLWho this might be right forAcute Myeloid Leukemia (AML)Myelodysplastic Syndromes (MDS) Ruijin Hospital 168